{"id":"https://openalex.org/W2007349116","doi":"https://doi.org/10.1097/01.cad.0000180117.93535.cf","title":"Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria","display_name":"Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria","publication_year":2005,"publication_date":"2005-09-15","ids":{"openalex":"https://openalex.org/W2007349116","doi":"https://doi.org/10.1097/01.cad.0000180117.93535.cf","mag":"2007349116","pmid":"https://pubmed.ncbi.nlm.nih.gov/16162974"},"language":"en","primary_location":{"id":"doi:10.1097/01.cad.0000180117.93535.cf","doi":"https://doi.org/10.1097/01.cad.0000180117.93535.cf","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.cad.0000180117.93535.cf","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029217625","display_name":"Carmen Blanco\u2010Aparicio","orcid":"https://orcid.org/0000-0002-3249-6595","observed_orcids":["https://orcid.org/0000-0002-3249-6595"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen Blanco-Aparicio","raw_affiliation_strings":["Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090488385","display_name":"Bel\u00e9n Peque\u00f1o","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Belen Peque\u00f1o","raw_affiliation_strings":["Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033015070","display_name":"Victoria Moneo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Victoria Moneo","raw_affiliation_strings":["Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029449169","display_name":"Lourdes Romero","orcid":"https://orcid.org/0000-0001-7893-5779","observed_orcids":["https://orcid.org/0000-0001-7893-5779"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lourdes Romero","raw_affiliation_strings":["Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063355877","display_name":"Juan Fernando Mart\u00ednez-Leal","orcid":"https://orcid.org/0000-0002-7538-0875","observed_orcids":["https://orcid.org/0000-0002-7538-0875"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan F. M. Leal","raw_affiliation_strings":["Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075350338","display_name":"Juan A. Velasco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Velasco","raw_affiliation_strings":["Lilly Research Laboratories, Alcobendas, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Alcobendas, Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111442153","display_name":"Jes\u00fas M. Fominaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jes\u00fas Fominaya","raw_affiliation_strings":["Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063985660","display_name":"Amancio Carnero","orcid":"https://orcid.org/0000-0003-4357-3979","observed_orcids":["https://orcid.org/0000-0003-4357-3979"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Amancio Carnero","raw_affiliation_strings":["Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5063985660"],"corresponding_institution_ids":["https://openalex.org/I4210089594"],"apc_list":null,"apc_paid":null,"fwci":0.6195,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.59494215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"16","issue":"9","first_page":"977","last_page":"987"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ly294002","display_name":"LY294002","score":0.9259999990463257},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/bax-translocation","display_name":"Bax translocation","score":0.7450000047683716},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.6629999876022339},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.8899999856948853},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8318061828613281},{"id":"https://openalex.org/C2780610907","wikidata":"https://www.wikidata.org/wiki/Q2273248","display_name":"Phosphatidylinositol","level":3,"score":0.7169625163078308},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6355043649673462},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.63341224193573},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5497850775718689},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5441251397132874},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5248886942863464},{"id":"https://openalex.org/C2776912716","wikidata":"https://www.wikidata.org/wiki/Q4042503","display_name":"LY294002","level":4,"score":0.5018889904022217},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.492364764213562},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.46891745924949646},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4452126920223236},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.43572941422462463},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.42439591884613037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3833889961242676},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34264522790908813},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31933510303497314},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1966027319431305},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08589184284210205},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07605764269828796}],"mesh":[{"descriptor_ui":"D000072160","descriptor_name":"Tumor Protein p73","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007890","descriptor_name":"Leiomyosarcoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007890","descriptor_name":"Leiomyosarcoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007890","descriptor_name":"Leiomyosarcoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016147","descriptor_name":"Genes, Tumor Suppressor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021381","descriptor_name":"Protein Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D025521","descriptor_name":"Tumor Suppressor Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051020","descriptor_name":"bcl-X Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051028","descriptor_name":"bcl-2-Associated X Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.cad.0000180117.93535.cf","doi":"https://doi.org/10.1097/01.cad.0000180117.93535.cf","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.cad.0000180117.93535.cf","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:16162974","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16162974","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1568317880","https://openalex.org/W1585517331","https://openalex.org/W1594020010","https://openalex.org/W1651860280","https://openalex.org/W1783498278","https://openalex.org/W1884542296","https://openalex.org/W1914067219","https://openalex.org/W1966292443","https://openalex.org/W1974547108","https://openalex.org/W1984418041","https://openalex.org/W1985731963","https://openalex.org/W1999653639","https://openalex.org/W2000079492","https://openalex.org/W2000932071","https://openalex.org/W2013105209","https://openalex.org/W2029219396","https://openalex.org/W2042848097","https://openalex.org/W2045086385","https://openalex.org/W2052750950","https://openalex.org/W2060346337","https://openalex.org/W2060796398","https://openalex.org/W2061932825","https://openalex.org/W2063685408","https://openalex.org/W2069508460","https://openalex.org/W2076627331","https://openalex.org/W2082888699","https://openalex.org/W2084708321","https://openalex.org/W2085233944","https://openalex.org/W2091019523","https://openalex.org/W2100470338","https://openalex.org/W2103446533","https://openalex.org/W2104461354","https://openalex.org/W2111309453","https://openalex.org/W2125649123","https://openalex.org/W2126787895","https://openalex.org/W2133701720","https://openalex.org/W2136217164","https://openalex.org/W2140967934","https://openalex.org/W2146854995","https://openalex.org/W2164712283","https://openalex.org/W2274924671","https://openalex.org/W6637019226","https://openalex.org/W6638090546","https://openalex.org/W6639250366","https://openalex.org/W6675182077","https://openalex.org/W6675637380","https://openalex.org/W6679679335","https://openalex.org/W6684039726","https://openalex.org/W6694700953"],"related_works":["https://openalex.org/W2081626155","https://openalex.org/W1568317880","https://openalex.org/W2019397219","https://openalex.org/W87044103","https://openalex.org/W2564360633","https://openalex.org/W2115532546","https://openalex.org/W2124592445","https://openalex.org/W7100475671","https://openalex.org/W2368699212","https://openalex.org/W2001932120"],"abstract_inverted_index":{"Apoptotic":[0],"pathways,":[1],"including":[2],"the":[3,33,36,74,87,122,127,130,138,156,164,173,182],"phosphatidylinositol-3-kinase":[4],"(PI3K)/AKT":[5],"survival":[6],"pathway,":[7],"are":[8],"altered":[9],"in":[10,14,120,137,155],"most":[11],"cancer":[12],"cells":[13],"relation":[15],"to":[16,86,153],"their":[17],"normal":[18],"counterparts":[19],"and":[20,109,142,160,168,181],"these":[21,63,118],"differences":[22],"may":[23],"present":[24],"an":[25],"excellent":[26],"therapeutic":[27],"window.":[28],"To":[29],"gain":[30],"insight":[31],"into":[32],"relevance":[34],"of":[35,62,69,124,129,163,175,193],"PI3K":[37,75,88,99,146],"pathway":[38,76],"as":[39,107],"a":[40],"target":[41],"for":[42,117,184,189],"drug":[43],"discovery":[44],"we":[45,55],"generated":[46],"tumor":[47,52],"cell":[48,64,81],"lines":[49,65,82],"from":[50],"different":[51,78],"samples":[53],"that":[54,67,98,113,133,145,186],"maintained":[56],"at":[57],"low":[58],"passage.":[59],"The":[60],"characterization":[61],"indicates":[66],"all":[68],"them":[70],"have":[71],"constitutively":[72],"activated":[73],"through":[77],"mechanisms.":[79],"All":[80],"were":[83],"differentially":[84],"sensitive":[85],"inhibitor":[89],"LY294002.":[90],"Our":[91],"data":[92],"also":[93],"support":[94],"previous":[95],"work":[96],"indicating":[97],"inhibition":[100,147],"might":[101,114,134,148],"help":[102],"classical":[103],"chemotherapeutic":[104,150,179],"treatments":[105],"such":[106],"gemcitabine":[108,143],"strengthen":[110],"suboptimal":[111],"doses":[112],"be":[115,135],"effective":[116],"purposes":[119],"decreasing":[121],"risk":[123],"side-effects.":[125],"Finally,":[126],"analysis":[128],"molecular":[131,191],"markers":[132],"implicated":[136],"synergism":[139,177],"between":[140,158,178],"LY294002":[141],"suggests":[144],"aid":[149],"treatment,":[151],"leading":[152],"changes":[154],"balance":[157],"anti-":[159],"pro-apoptotic":[161],"molecules":[162],"Bcl-2":[165],"family,":[166],"Bcl-XL":[167],"Bax.":[169],"These":[170],"results":[171],"facilitate":[172],"exploration":[174],"potential":[176],"treatment":[180],"search":[183],"others":[185],"can":[187],"account":[188],"similar":[190],"mechanisms":[192],"cooperation.":[194]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}